Open Access
SHS Web Conf.
Volume 158, 2023
2nd International Academic Conference on Public Art and Human Development (ICPAHD 2022)
Article Number 02004
Number of page(s) 5
Section Humanities Education and Socio-Historical Development
Published online 13 February 2023
  1. M G von Herrath, M Yokoyama, J Dockter, M B Oldstone, J L Whitton. CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge. Journal of Virology. 70.2.1072-1079.1996. [CrossRef] [Google Scholar]
  2. Parinaz Aliahmad, Jonathan Kaye. Development of all CD4 T lineages requires nuclear factor TOX. J Exp Med 21 January 2008; 205 (1): 245–256. [CrossRef] [Google Scholar]
  3. Lisa A. Urry, Micheal L. Cain, Steven A. Wasserman, Peter V. Minorsky, Rebecca B. Orr, Neil A. Campbell. Campbell Biology, 12th Edition. [Google Scholar]
  4. Brown TR. I am the Berlin patient: a personal reflection. AIDS Res Hum Retroviruses. 2015 Jan;31(1):2-3. [CrossRef] [Google Scholar]
  5. Letisia Marquez. Patient with HIV achieves remission following stem cell transplant at City of Hope. | July 27, 2022. [Google Scholar]
  6. JingMei Hsu, Koen Van Besien, Marshall J. Glesby, et al. HIV-1 remission with CCR5Δ32Δ32 haplo-cord transplant in a US woman: IMPAACT P1107. In: Program and abstracts of the Conference on Retroviruses and Opportunistic Infections, 12-16, February 2022, David Geffen School of Medicine at University of California. Abstract 65. [Google Scholar]
  7. HIV cure of the ‘London Patient’ is confirmed and a third case of long-term viral remission is presented: the ’Düsseldorf Patient’. The IciStem international consortium, coordinated by IrsiCaixa. News, 10/03/2020. [Google Scholar]
  8. The Lancet Hiv. Like London buses, two putative cure cases arrive at once. Lancet HIV. 2019 Apr;6(4):e205. [CrossRef] [Google Scholar]
  9. Jensen B-E, Knops E, Lübke N, et al. Analytic treatment interruption (ATI) after allogenic CCR5 delta-32 HSCT for AML in 2013. In: Program and abstracts of the Conference on Retroviruses and Opportunistic Infections, 4 – 7, March 2019, Seattle, Washington. Abstract 394. [Google Scholar]
  10. The often-overlooked Düsseldorf patient | CATIE Canada’s source for HIV and hepatitis C information. [Google Scholar]
  11. Moreno S, Perno CF, Mallon PW, Behrens G, Corbeau P, Routy JP, Darcis G. Two-drug vs. threedrug combinations for HIV-1: Do we have enough data to make the switch? HIV Med. 2019 Apr;20 Suppl 4:2-12. [CrossRef] [Google Scholar]
  12. Artyomov MN, Lis M, Devadas S, Davis MM, Chakraborty AK. CD4 and CD8 binding to MHC molecules primarily acts to enhance Lck delivery. Proc Natl Acad Sci U S A. 2010 Sep 28;107(39):16916-21. [CrossRef] [Google Scholar]
  13. National Cancer Institute. Acute Myeloid Leukemia Treatment (PDQ®)–Patient Version – NCI. [Google Scholar]
  14. Reeves JD, Hibbitts S, Simmons G, McKnight A, Azevedo-Pereira JM, Moniz-Pereira J, Clapham PR. Primary human immunodeficiency virus type 2 (HIV2) isolates infect CD4-negative cells via CCR5 and CXCR4: comparison with HIV-1 and simian immunodeficiency virus and relevance to cell tropism in vivo. J Virol. 1999 Sep;73(9):7795-804. [CrossRef] [Google Scholar]
  15. Beyond the Berlin, London and Düsseldorf patients | CATIE Canada’s source for HIV and hepatitis C information. [Google Scholar]
  16. Ye L, Wang J, Beyer AI, Teque F, Cradick TJ, Qi Z, Chang JC, Bao G, Muench MO, Yu J, Levy JA, Kan YW. Seamless modification of wild-type induced pluripotent stem cells to the natural CCR5Δ32 mutation confers resistance to HIV infection. Proc Natl Acad Sci U S A. 2014 Jul 1;111(26):9591-6. [CrossRef] [Google Scholar]
  17. Schiller GJ. High-risk acute myelogenous leukemia: treatment today ... and tomorrow. Hematology Am Soc Hematol Educ Program. 2013;2013:201-8. [CrossRef] [Google Scholar]
  18. Malgieri A, Kantzari E, Patrizi MP, Gambardella S. Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art. Int J Clin Exp Med. 2010 Sep 7;3(4):248-69. [Google Scholar]
  19. Xu L, Yang H, Gao Y, Chen Z, Xie L, Liu Y, Liu Y, Wang X, Li H, Lai W, He Y, Yao A, Ma L, Shao Y, Zhang B, Wang C, Chen H, Deng H. CRISPR/Cas9Mediated CCR5 Ablation in Human Hematopoietic Stem/Progenitor Cells Confers HIV-1 Resistance In Vivo. Mol Ther. 2017 Aug 2;25(8):1782-1789. [CrossRef] [Google Scholar]
  20. Xie, Y., Zhan, S., Ge, W. et al. The potential risks of C-C chemokine receptor 5-edited babies in bone development. Bone Res 7, 4 (2019). [CrossRef] [Google Scholar]
  21. “Berlin patient: First person cured of HIV, Timothy Ray Brown, dies”. BBC News. 30 September 2020. [Google Scholar]
  22. Gupta RK, Abdul-Jawad S, McCoy LE, Mok HP, Peppa D, Salgado M, Martinez-Picado J, Nijhuis M, Wensing AMJ, Lee H, Grant P, Nastouli E, Lambert J, Pace M, Salasc F, Monit C, Innes AJ, Muir L, Waters L, Frater J, Lever AML, Edwards SG, Gabriel IH, Olavarria E. HIV-1 remission following CCR5Δ32/Δ32 haematopoietic stem-cell transplantation. Nature. 2019 Apr;568(7751):244-248. [CrossRef] [Google Scholar]
  23. [Google Scholar]
  24. Indranil Mallick, MD. An Overview of Nodular Sclerosing Hodgkin Lymphoma. | Updated on November 01, 2019. [Google Scholar]
  25. Dickter J et al. The ‘City of Hope’ Patient: prolonged HIV-1 remission without antiretrovirals (ART) after allogeneic hematopoietic stem cell transplantation (aHCT) of CCR5Δ32/Δ32 donor cells for acute myelogenous leukemia (AML). AIDS 2022, 29 July – 2 August 2022. Oral late-breaker abstract OALBB0104. [Google Scholar]
  26. Liz Highleyman. California man appears to be another person cured of HIV after a stem cell transplant. | 2 August 2022. [Google Scholar]
  27. Roura S, Pujal JM, Gálvez-Montón C, Bayes-Genis A. The role and potential of umbilical cord blood in an era of new therapies: a review. Stem Cell Res Ther. 2015 Jul 2;6(1):123. [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.